De Burlo Group’s Labcorp LH Stock Holding History

De Burlo Group’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-38,761	Closed	-$4.78M	–	107
2017 Q1	$4.78M	Buy	+38,761	New	+$4.59M	1.04%	35

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

De Burlo Group's LH Position: Q2 2017 in Review

De Burlo Group sold out of Labcorp (LH) in Q2 2017, closing a stake of 38,761 shares — an estimated $4.78M sold.

De Burlo Group first reported a position in LH in Q1 2017 and held it in 1 quarter. The position peaked at $4.78M in Q1 2017. 691 funds tracked by Wall St. Rank hold LH as of Q2 2017.

De Burlo Group reported no remaining Labcorp position as of Q2 2017 after selling out during the quarter.
De Burlo Group sold 38,761 Labcorp shares in Q2 2017, an estimated $4.78M.
De Burlo Group first reported a position in Labcorp in Q1 2017 and held it in 1 quarter.
De Burlo Group's Labcorp position peaked at $4.78M in Q1 2017.
691 funds tracked by Wall St. Rank held Labcorp as of Q2 2017.

Based on De Burlo Group's 13F filing for Q2 2017, filed 3 Aug 2017.